Shavit Capital

• PolyPid Provides Positive Regulatory Update for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Colorectal SurgeryJanuary 24, 2023
• LEVI STRAUSS & CO. TAPS FASHION FOR GOOD TO START HOME-COMPOSTABLE PACKAGING TRIALJanuary 16, 2023
• PolyPid Announces Publication in the American Journal of Surgery of Phase 2 Clinical Trial Post-hoc Analysis for D-PLEX₁₀₀ in the Prevention of Surgical Site Infections in Abdominal SurgeryJanuary 3, 2023
• Chemomab Reports Top-Line Results from CM-101 Phase 2a Liver Fibrosis Biomarker Trial in NASH PatientsJanuary 3, 2023
• Lightricks expands to image editing for desktopDecember 22, 2022
• Tulsa ER & Hospital Adopts Trailblazing MeMed BV® TestDecember 22, 2022
• Chemomab Reports Independent Drug Monitoring Committee Safety Review of CM-101 Phase 2 Trial in Primary Sclerosing CholangitisDecember 21, 2022
• Novachem offers metered-dosing inhaler to Australian patientsDecember 21, 2022
• AI Will Drive The Evolution Of Human CreativityDecember 13, 2022
• Gamida Cell Announces Closing of $25 Million Financing With HighbridgeDecember 12, 2022

• 1
• 2
• 3
• 4
• ...
• 42
• »